Literature DB >> 25180450

Neutrophil CD64 expression as an important diagnostic marker of infection and sepsis in hospital patients.

Mariela Granero Farias1, Natália Pieruccini de Lucena2, Suzane Dal Bó3, Simone Martins de Castro4.   

Abstract

INTRODUCTION: Infection and sepsis are major health problems. Therefore, the need for improved diagnostic indicators, as well as for better therapeutic monitors in the treatment of infection, remains, since the current diagnostic tools have low specificity and passed through minimal changes in the last two decades.
OBJECTIVE: The aim of this study was to establish the correlation of neutrophil CD64 with indicators of infection and sepsis.
METHODS: We established the correlation of the neutrophil CD64 expression with the following variables: complete white blood count, band count, neutrophils, C-reactive protein (CRP), cultures, flags released by automated hematology analyzers and clinical groups. Accordingly clinical groups were divided into two: patients "without clinical or laboratory evidence of infection or inflammatory process" and "clinical or laboratory evidence of a systemic inflammatory response (SIRS) and systemic sepsis" based upon identification of organisms by culture. We analyzed 93 whole blood samples anticoagulated with K3EDTA of patients admitted in the Intensive Care Unit (ICU) of a community hospital.
RESULTS: The expression CD64 was statistically significant with clinical groups, flags, and neutrophils and was not significantly correlated with total count of white blood cells and cultures.
CONCLUSION: Our results indicate that high expression of CD64 is an indicator important in the diagnosis of infection and sepsis.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CD64; Diagnosis; Flow cytometry; Infection

Mesh:

Substances:

Year:  2014        PMID: 25180450     DOI: 10.1016/j.jim.2014.07.011

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  Neutrophil CD64 Expression as a Diagnostic Marker in Patients Hospitalized with Exacerbations of COPD: A Prospective Observational Study.

Authors:  Elena Titova; Marthe Wedø Aune; Kristin Fonn; Anne Hildur Henriksen; Arne Åsberg
Journal:  Lung       Date:  2015-07-15       Impact factor: 2.584

2.  Human Neutrophil Lipocalin as a Superior Diagnostic Means To Distinguish between Acute Bacterial and Viral Infections.

Authors:  Per Venge; Lena Douhan-Håkansson; Daniel Garwicz; Christer Peterson; Shengyuan Xu; Karlis Pauksen
Journal:  Clin Vaccine Immunol       Date:  2015-07-01

3.  nCD64 index as a prognostic biomarker for mortality in acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Ning Xu; Juan Chen; Xin Chang; Jingwen Zhang; Qinghua Liu; Aljun Li; Dianjie Lin
Journal:  Ann Saudi Med       Date:  2016 Jan-Feb       Impact factor: 1.526

Review 4.  Biomarkers for Sepsis: What Is and What Might Be?

Authors:  Bethany M Biron; Alfred Ayala; Joanne L Lomas-Neira
Journal:  Biomark Insights       Date:  2015-09-15

Review 5.  Paving the way for precision medicine v2.0 in intensive care by profiling necroinflammation in biofluids.

Authors:  Tom Vanden Berghe; Eric Hoste
Journal:  Cell Death Differ       Date:  2018-09-10       Impact factor: 15.828

Review 6.  Application of Machine Learning for Cytometry Data.

Authors:  Zicheng Hu; Sanchita Bhattacharya; Atul J Butte
Journal:  Front Immunol       Date:  2022-01-03       Impact factor: 7.561

7.  Identification of hub genes for adult patients with sepsis via RNA sequencing.

Authors:  Qian Zhang; Yingchun Hu; Peiyao Wei; Liu Shi; Lei Shi; Jianzhou Li; Yalei Zhao; Yunru Chen; Xi Zhang; Feng Ye; Xiaojing Liu; Shumei Lin
Journal:  Sci Rep       Date:  2022-03-24       Impact factor: 4.996

8.  Assessment of continuous neutrophil CD64 index measurement for diagnosing sepsis and predicting outcome in a Chinese pediatric intensive care unit: a prospective study.

Authors:  Wei Cui; Yuanyuan Xu; Hui Fang; Wenjia Tong; Liran Zhu; Danqun Jin; Haipeng Liu
Journal:  Transl Pediatr       Date:  2021-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.